Search Results

Search Results for "transvaginal mesh"

• J&J’s new branding a response to long-standing problems
  A piece in the New York Times on Johnson & Johnson’s new corporate branding campaign says the company urgently needed to distance itself from the “bad press of product recalls and pending litigation,” of which it experienced much lately. In 2010, the story points out, Johnson & Johnson...

• J&J trying to recover from setbacks
  Although Johnson & Johnson’s overall profit fell 10.6 percent to $3.5 billion in the first quarter of 2013, over-the-counter sales through the company’s consumer division are up 14 percent in the United States, according to a story in the Philadelphia Inquirer. The company is putting more Ty...

• Investing blog warns about J&J
  An investing blog on CNBC.com warns potential investors about health care giant Johnson & Johnson. The stock is already up more than 22 percent on the year, the blog entry says, and trading at a price/earnings ratio more than twice that of rival Abbott Laboratories. But the entry points out that...

• J&J baby powder contaminated with carcinogen
  According to a story in the International Business Times, a batch of baby powder from a Johnson & Johnson plant in India was found to be contaminated with a carcinogen. That finding prompted the Food and Drug Administration to cancel Johnson & Johnson’s license to manufacture the powder at...

• J&J undertakes campaign to repair image
  A story in Forbes describes Johnson & Johnson’s new global branding campaign, which will cost the medical products giant an estimated $20 million to $30 million for the remainder of the year. The campaign, the company’s first in more than a decade, features the tagline: “For all you love, ...

• Johnson & Johnson shareholders unhappy with management
  A story in the Washington Post says that several Johnson & Johnson shareholders spoke of their dissatisfaction with the company during their annual meeting recently. Their complaints focused on a long string of product recalls, ethical lapses and excessive executive pay. In 2010, the company’s...

• Less invasive treatment available for urinary incontinence
  According to the Mayo Clinic, a number of treatment options for urinary incontinence are available, depending on the severity and underlying cause of the condition. Doctors may eventually recommend a combination of treatments. But in most cases, doctors will recommend the least invasive approaches f...

• Problems drag down J&J profits for quarter
  Johnson & Johnson, the worlds’ largest maker of health care products, has announced that its first-quarter profits were down, but that its earnings nevertheless beat analysts’ estimates. According to a story in The Star Ledger out of Newark, sales for the quarter rose to $17.5 billion, an in...

• Court sides with J&J on patent issue
  A U.S. appeals court has sided with health care giant Johnson & Johnson – throwing out an earlier $482 million verdict in a patent infringement case, according to a story in the Newark Star Ledger. A doctor had claimed Johnson & Johnson infringed on the patent for his invention, which used...

• Column describes pelvic organ prolapse
  A column by local physician Christie Iverson, MD, in the Bismarck Tribune out of North Dakota describes pelvic organ prolapse. Iverson writes that the condition is basically what happens when a woman’s pelvic floor weakens and the vaginal walls protrude, or a weakened uterus descends into the vagi...